...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New PP on SEDAR

Or something new or developing rapidly, that makes the timeframe believable and enticing?

Maybe, if others on the PPs were accepting 2023-11-14 for warrants instead of 2028.

One can attempt to read the tea leaves, with optimism and hope?

I just checked.  I can't find optimism and hope on my list of investments strategies.

RVX is rocketing today, with huge volume and a solid increase in pps percentage.

The bid of 25 cents this morning is already looking like a selling opportunity.  If I still had RVX shares, I'd sell on the news, if news is coming.

 

 

Share
New Message
Please login to post a reply